An oncology expert explains how clinical and non-clinical evidence impact the clinical pathway decision-making for patients with NSCLC. Edward Arrowsmith, MD: We have a couple ways that we're tracking ...
The free virtual series extends Clinical Pathways Congress with timely insights into evidence-based pathways, value assessment, and access. By extending Clinical Pathways Congress throughout the year, ...
The US Food and Drug Administration (FDA) has submitted its budget proposal to Congress, outlining its spending priorities for fiscal year 2027. The budget request totals $7.2 billion, including $3.3 ...
At the AMCP Annual Meeting this week, experts from Prime Therapeutics said virtual navigation and clinical pathways are ...
Click here to view video highlights from this interview. AJMC ®: Kaiser Permanente has set up a clinical pathway for the use of SGLT2 [sodium-glucose cotransporter-2] inhibitors for patients with ...
Faster Medicare Coverage. The Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration ...
Despite advances in clinical cancer care, cancer survivors frequently report a range of persisting issues, unmet needs, and concerns that limit their ability to participate in life roles and reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results